Report Publication Announcement • Dec 15, 2014
Report Publication Announcement
Open in ViewerOpens in native device viewer
December 15, 2014 (Lure, France) – Vétoquinol published its calendar of financial communication for 2015.
| January 22, 2015 | 2014 Annual revenues (after market) |
|---|---|
| March 23, 2015 | 2014 Annual results (after market) Investor's presentation on March 24 |
| April 14, 2015 | 2015 First quarter revenues (after market) |
| May 20, 2015 | Annual shareholders' meeting |
| June 4, 2015 | Dividend distribution |
| July 30, 2015 | 2015 Interim revenues and interim results (after market) |
| October 22, 2015 | 2015 Third quarter revenues (after market) |
| January 21, 2016 | 2015 Annual revenues (after market) |
Next update: 2014 Annual revenues, January 22, 2015 after market close
Vétoquinol is a leading global player in the animal health sector serving both the livestock (cattle and pigs) and pet (dogs and cats) markets.
An independent pure player, Vétoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.
Since its foundation in 1933, Vétoquinol has pursued a strategy combining innovation with geographical diversification. The Group's hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vétoquinol employs 1,977 people. Vétoquinol has been listed on NYSE Euronext Paris since 2006 (symbol: VETO).
For more information, contact:
VETOQUINOL KEIMA COMMUNICATION Investor Relations Marie-Josée AUBRY-ROTA Tel.: +33 (0)3 84 62 59 88 [email protected]
Investor Relations and Media Relations Emmanuel DOVERGNE Tel.: +33 (0)1 56 43 44 63 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.